Programme


09:00 - 09:30

Registration + coffee

09:30 - 09:40

Welcome to London

09:40 - 10:40

Paper Session 1 (theme TBC)

09:40

Abstract 1

09:50

Abstract 2

10:00

Abstract 3

10:10

Abstract 4

10:20

Abstract 5

10:30

Questions & discussion

10.40-11.10

Keynote Speaker- Dr Fernanda Amary, RNOH

“Translating 100,000 Genomes into clinical practice”

11:10-11.30

Coffee + poster viewing + industry interaction

11.30-12.45

Paper Session 2 (theme TBC)

11:30

Abstract 1

11.40

Abstract 2

11:50

Abstract 3

12:00

Abstract 4

12:10

Abstract 5

12.20

Questions & discussion

12:30:13.00

Keynote Speaker - Dr Michiel Van de Sande, Leiden. “Collaboration and the evolution of PERSARC”

13:00 – 13.45

Lunch + poster viewing + industry interaction

13.45

Paper Session 3 (theme TBC)

13:45

Abstract 1

13:55

Abstract 2

14:05

Abstract 3

14:15

Abstract 4

14.25

Abstract 5

14.35

Questions & discussion

14:45-15:15

Keynote Speaker- Prof Tim Briggs CBE, RNOH “GIRFT and Cancer”

15:15-16.00

Afternoon refreshments + poster viewing + industry interaction

16:00 – 17:00

Paper Session 4 (theme TBC)

16:00

Abstract 1

16:10

Abstract 2

16:20

Abstract 3

16:30

Abstract 4

16:40

Abstract 5

16:50

Questions & discussion

17:00-17.15

Keynote Speaker- Prof Rob Ashford, President BOOS. “An update on metastatic bone disease”

17:15-17:30

Prize Giving

17:30 - 18:00

BOOS AGM

18:00

End of conference

19.00

Conference Dinner - St Pancras by Searcy's



Keynote Speakers

Dr Fernanda Amary, RNOH

Dr Fernanda Amary trained and worked as a pathologist and associate professor of pathology in Sao Paulo, Brazil until 2009. She completed her MPhil (2001) and PhD (2007) with focus in molecular genetics of sarcomas.

In 2010 she moved to the UK to take a post as a specialist bone and soft tissue histopathologist at the Royal National Orthopaedic Hospital. She is a full-time Consultant bone and soft tissue pathologist, Clinical Lead for Molecular Pathology and Honorary Associate Professor at University College London Cancer Institute.

Her research focus is in molecular genetic markers for these tumours. She has developed and maintains a teaching application for mobile devices on bone and soft tissue tumour with over 950 annotated images and 10000 users worldwide.

Dr Michiel A.J. Van de Sande, Leiden University Medical Centre

Michiel van de Sande currently works as a senior (paediatric) Orthopaedic Surgeon in the Leiden University Medical Center (LUMC) and the Princes Maxima Center for paediatric oncology in Utrecht where he surgically treats paediatric, AYA and adult patients with bone and soft tissue tumours. He started in Leiden in 2010 as an Senior Orthopaedic Surgeon, immediately after completing his Orthopaedic training that was followed by a fellowship in paediatric Orthopaedic oncology at the Nuffield Orthopaedic Centre in Oxford.

His surgical Speciality focuses on the treatment of paediatric, AYA and adult patients with Bone and soft tissue sarcomas and paediatric orthopaedics (oncology and limb reconstruction).

His scientific activity started with the design of (inter)national sarcoma databases and registrations. Research lines have been set up in recent years which have an international collaborative basis, such as multicenter studies on giant cell tumours of the joint and bone, soft tissue sarcomas, chondrosarcomas, adamantinoma, Osteo- and Ewing Sarcoma. The Personalised Sarcoma Care project aims to support patients and multidisciplinary teams with up to date information on prognosis now and in the long term, in order to personalise in clinical decision making for both treatment and follow-up of sarcoma patients. He has published more than 100 peer reviewed papers and book-chapters; His research was funded by several scientific grants; e.g. the Dutch Cancer Fund (KWF), Alpe-D’huzes and Team Westland.

Prof Tim Briggs CBE, RNOH

Tim was appointed to the Royal National Orthopaedic Hospital as Consultant in 1992. His specialist interests are in orthopaedic oncology as well as surgery to the hip and knee. He was Medical Director at the RNOH for 15 years, ensuring a re-build and was President of the British Orthopaedic Association in 2014.

He was appointed as National Director for Clinical Quality and Efficiency for the NHS in September 2015 and has been asked to lead and roll out his GIRFT methodology, developed in orthopaedics, across all surgical and medical specialities within the provider network. In January 2019, he was made National Director of Clinical Improvement for the NHS.

Professor Briggs was made a Commander of the Most Excellent Order of the British Empire (CBE) in the 2018 New Year’s Honours List for services to the surgical profession.

Prof Robert U. Ashford, University Hospitals of Leicester

Rob was appointed at Leicester as a Consultant Orthopaedic & Musculoskeletal Tumour Surgeon in 2008, working jointly at Nottingham University Hospitals, following fellowships in Sydney and at the RNOH. He is the lead clinician of the East Midlands Sarcoma Service. He clinical practice is orthopaedic oncology and lower limb arthroplasty.

His research interests are metastatic bone disease, palliative orthopaedic surgery, genetics of soft tissue sarcoma and outcome measures in sarcoma. He was co-chair of the BOOS working party on surgical management of metastatic bone disease.

He was chosen as an ABC travelling fellow in 2014 and in 2019 he was both promoted to Honorary Professor at the Leicester Cancer Research Centre and elected President of the British Orthopaedic Oncology Society. He is grateful that Saracens have ensured Leicester Tigers have avoided relegation.


Abstract Submission

Submit your abstracts here.